MetaCap

HeartSciences (HSCS) vs Milestone Scientific (MLSS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

HeartSciences (HSCS) has outperformed Milestone Scientific (MLSS) over the past year, losing 6.4% versus a loss of 23.4%. Milestone Scientific is the larger company by market cap ($32.6 million vs $14.7 million), about 2.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HSCS-6.18%MLSS-21.28%
+45%-8%-60%
Oct 8, 20251 yearOct 7, 2026
HSCS-98.32%MLSS-56.63%
+72%-18%-107%
Jun 13, 20225 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HSCS versus MLSS key metrics
MetricHSCSMLSS
Share price$3.04$0.36
Market cap$14.73M$32.62M
1-day change-12.89%-2.70%
YTD return+12.94%+33.33%
1-year return-6.43%-23.40%
5-year return—-82.94%
EPS (TTM)$-3.21$-0.04
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$5.25$0.58
52-week low$1.63$0.22
Distance from 52-week high-42.10%-37.93%
Analyst consensusbuynone
Avg. price target upside+294.74%+247.22%
Average volume154.08K128.06K
Shares outstanding4.84M90.61M
Employees1415
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Instruments & Supplies

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Milestone Scientific is about 2.2 times larger than HeartSciences by market value ($32.62M vs $14.73M).
  • HSCS has outperformed MLSS by 17.0 percentage points over the past year.

About HeartSciences

HSCS stock →

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.

Healthcare · Medical Devices · 14 employees

About Milestone Scientific

MLSS stock →

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.

Healthcare · Medical Instruments & Supplies · 15 employees

HSCS vs MLSS FAQ

Which is bigger, HeartSciences or Milestone Scientific?

Milestone Scientific (MLSS) is larger, with a market capitalization of $32.62M compared with $14.73M for HeartSciences (HSCS).

Which stock has performed better over the past year, HSCS or MLSS?

HSCS returned -6.43% over the past 12 months, compared with -23.40% for MLSS (price return, excluding dividends). Past performance does not predict future results.

Are HeartSciences and Milestone Scientific in the same industry?

Both are in the Healthcare sector, but in different industries: Medical Devices for HeartSciences and Medical Instruments & Supplies for Milestone Scientific.

More comparisons